FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563069972> ?p ?o ?g. }

• W2563069972 abstract "Abstract Background Utilization of intravenous immune globulin (IVIG) is increasing in Canada and worldwide despite few and no new labeled indications. In 2007, Canadian Blood Services in collaboration with the National Advisory Committee on Blood and Blood Products convened a panel of solid organ transplantation (SOT) experts (kidney, heart, lung, and liver) and methodologists to develop an evidence-based practice guideline for the use of IVIG in patients undergoing SOT. The objectives of this guideline are to examine the evidence for the use of IVIG in patients who are candidates for SOT and are sensitized to HLA or ABO antigens, to provide guidance for Canadian practitioners involved in the care of these patients and transfusion medicine specialists on the use of IVIG. Methods: The panel identified clinical areas of SOT that would benefit from treatment with IVIG and generated key clinical questions. A systematic, expert and bibliography literature search up to July 2008 was conducted to ensure all relevant publications were included. The panel generated recommendations based on the evidence. The levels of evidence and grading of recommendations were adapted from the Canadian Task Force on Preventative Health Care. To validate conclusions and recommendations, the practice guideline will be sent to physicians involved in solid organ transplantation in Canada and a patient representative. Recommendations from practitioner feedback will be incorporated, and the guideline will be disseminated to all physicians involved in the care of patients receiving solid organ transplantation in Canada to aid implementation of the guideline. The National Advisory Committee of Blood and Blood Products in Canada will subsequently assess the performance of the guideline and will renew the guideline at timely intervals. Results and Conclusions: The research questions developed by the panel were: Is there evidence that the use of IVIG reduces morbidity and mortality for patients undergoing SOT who are sensitized (HLA or ABO) in the perioperative setting and are sensitized experiencing acute graft rejection or experiencing chronic graft rejection? 791 citations were retrieved, and panel members identified 3 additional citations. 51 reports and a systematic review were used for this guideline. These reports were limited by inconsistent definitions of sensitization, inconsistent reporting of the type and titre of the antibody, the assays used to detect HLA antibodies, the response criteria and dosing schedules for IVIG. Thus, a consensus process was used to account for the poor evidence. The use of IVIG was associated with decreased sensitization and acceptable morbidity and mortality in living donor kidney transplantation. IVIG has been used with several other modalities for ABO-incompatible kidney transplantation and it was difficult from the existing literature to separate outcomes based on a single modality. There was also limited data on the perioperative use of IVIG in renal transplantation. IVIG was shown to be effective in combination with plasmapheresis for acute antibody mediated rejection of the kidney; however the role of IVIG was not clear for other forms of rejection. There were also several methodological limitations in the literature assessing IVIG for cardiac transplantation and only limited data were available to assess the use of IVIG for lung or liver transplantation. Future studies are needed to define the role of IVIG in solid organ transplantation and should capture the following elements: impact on antibody (specificity and titres), transplant rates, time to transplantation, graft function, graft survival, and rejection (cellular and antibody mediated)." @default.
• W2563069972 created "2017-01-06" @default.
• W2563069972 creator A5011976722 @default.
• W2563069972 creator A5020473629 @default.
• W2563069972 creator A5020996962 @default.
• W2563069972 creator A5021437066 @default.
• W2563069972 creator A5024317259 @default.
• W2563069972 creator A5036458953 @default.
• W2563069972 creator A5037155506 @default.
• W2563069972 creator A5038480610 @default.
• W2563069972 creator A5039041999 @default.
• W2563069972 creator A5056010181 @default.
• W2563069972 creator A5067482832 @default.
• W2563069972 creator A5074377449 @default.
• W2563069972 creator A5076261121 @default.
• W2563069972 creator A5079973794 @default.
• W2563069972 creator A5091299639 @default.
• W2563069972 date "2008-11-16" @default.
• W2563069972 modified "2023-09-30" @default.
• W2563069972 title "The Use of IVIG for Solid Organ Transplantation: An Evidence Based Practice Guideline" @default.
• W2563069972 doi "https://doi.org/10.1182/blood.v112.11.4666.4666" @default.
• W2563069972 hasPublicationYear "2008" @default.
• W2563069972 type Work @default.
• W2563069972 sameAs 2563069972 @default.
• W2563069972 citedByCount "0" @default.
• W2563069972 crossrefType "journal-article" @default.
• W2563069972 hasAuthorship W2563069972A5011976722 @default.
• W2563069972 hasAuthorship W2563069972A5020473629 @default.
• W2563069972 hasAuthorship W2563069972A5020996962 @default.
• W2563069972 hasAuthorship W2563069972A5021437066 @default.
• W2563069972 hasAuthorship W2563069972A5024317259 @default.
• W2563069972 hasAuthorship W2563069972A5036458953 @default.
• W2563069972 hasAuthorship W2563069972A5037155506 @default.
• W2563069972 hasAuthorship W2563069972A5038480610 @default.
• W2563069972 hasAuthorship W2563069972A5039041999 @default.
• W2563069972 hasAuthorship W2563069972A5056010181 @default.
• W2563069972 hasAuthorship W2563069972A5067482832 @default.
• W2563069972 hasAuthorship W2563069972A5074377449 @default.
• W2563069972 hasAuthorship W2563069972A5076261121 @default.
• W2563069972 hasAuthorship W2563069972A5079973794 @default.
• W2563069972 hasAuthorship W2563069972A5091299639 @default.
• W2563069972 hasConcept C141071460 @default.
• W2563069972 hasConcept C141330323 @default.
• W2563069972 hasConcept C142724271 @default.
• W2563069972 hasConcept C17744445 @default.
• W2563069972 hasConcept C177713679 @default.
• W2563069972 hasConcept C19648533 @default.
• W2563069972 hasConcept C199539241 @default.
• W2563069972 hasConcept C204787440 @default.
• W2563069972 hasConcept C2779473830 @default.
• W2563069972 hasConcept C2780182762 @default.
• W2563069972 hasConcept C2911091166 @default.
• W2563069972 hasConcept C512399662 @default.
• W2563069972 hasConcept C71924100 @default.
• W2563069972 hasConceptScore W2563069972C141071460 @default.
• W2563069972 hasConceptScore W2563069972C141330323 @default.
• W2563069972 hasConceptScore W2563069972C142724271 @default.
• W2563069972 hasConceptScore W2563069972C17744445 @default.
• W2563069972 hasConceptScore W2563069972C177713679 @default.
• W2563069972 hasConceptScore W2563069972C19648533 @default.
• W2563069972 hasConceptScore W2563069972C199539241 @default.
• W2563069972 hasConceptScore W2563069972C204787440 @default.
• W2563069972 hasConceptScore W2563069972C2779473830 @default.
• W2563069972 hasConceptScore W2563069972C2780182762 @default.
• W2563069972 hasConceptScore W2563069972C2911091166 @default.
• W2563069972 hasConceptScore W2563069972C512399662 @default.
• W2563069972 hasConceptScore W2563069972C71924100 @default.
• W2563069972 hasLocation W25630699721 @default.
• W2563069972 hasOpenAccess W2563069972 @default.
• W2563069972 hasPrimaryLocation W25630699721 @default.
• W2563069972 hasRelatedWork W1964495885 @default.
• W2563069972 hasRelatedWork W1965704891 @default.
• W2563069972 hasRelatedWork W1989327659 @default.
• W2563069972 hasRelatedWork W1996858117 @default.
• W2563069972 hasRelatedWork W2016487109 @default.
• W2563069972 hasRelatedWork W2021560214 @default.
• W2563069972 hasRelatedWork W2034669011 @default.
• W2563069972 hasRelatedWork W2044023744 @default.
• W2563069972 hasRelatedWork W2045354022 @default.
• W2563069972 hasRelatedWork W2151741557 @default.
• W2563069972 hasRelatedWork W2171094890 @default.
• W2563069972 hasRelatedWork W2175026415 @default.
• W2563069972 hasRelatedWork W2284880561 @default.
• W2563069972 hasRelatedWork W2531163776 @default.
• W2563069972 hasRelatedWork W2592871544 @default.
• W2563069972 hasRelatedWork W2599884304 @default.
• W2563069972 hasRelatedWork W2884294948 @default.
• W2563069972 hasRelatedWork W3009608962 @default.
• W2563069972 hasRelatedWork W3097630077 @default.
• W2563069972 hasRelatedWork W3146598220 @default.
• W2563069972 isParatext "false" @default.
• W2563069972 isRetracted "false" @default.
• W2563069972 magId "2563069972" @default.
• W2563069972 workType "article" @default.